Skip to main content

Web Exclusives

FDA Approvals
Opdivo First FDA-Approved Immunotherapy for First-Line Treatment of Advanced Gastric Cancer
Read More
FDA Approvals
Keytruda Received FDA Approval for First-Line Treatment of HER2-Positive Advanced Gastric Cancer
Read More
FDA Approvals
Trodelvy Receives New Indication for Advanced Urothelial Cancer
Read More
FDA Approvals
Sarclisa Receives New Indication for Relapsed or Refractory Multiple Myeloma
Read More
FDA Approvals
FDA Alert: Pepaxto (Melphalan Flufenamide) Associated with Increased Risk of Death in Postmarketing Clinical Trial
Read More
Practice Management
Global Issues Driving US Healthcare Trends in 2021 and 2022
F. Randy Vogenberg, PhD; John Santilli, MBA
Read More
Perspectives
Concerns Related to Benefits and Harms of Real-World Shared Decision-Making for Lung Cancer Screening
James L. Mulshine, MD; David F. Yankelevitz, MD; Bruce Pyenson, FSA, MAAA
Read More
FDA Approvals
Jemperli First FDA-Approved Immunotherapy for Advanced Endometrial Cancer with dMMR Biomarker
Read More
FDA Approvals
Rybrevant First FDA-Approved Therapy for NSCLC with EGFR Exon 20 Insertion Mutations
Read More
FDA Approvals
Lumakras First FDA-Approved Therapy for Advanced or Metastatic NSCLC with KRAS G12C Mutation
Read More
Page 12 of 37
Results 111 - 120 of 362